Small molecules as antagonists of co-inhibitory pathways for cancer immunotherapy: a patent review (2018-2019)-Reference-Cited by-同舟云学术

Small molecules as antagonists of co-inhibitory pathways for cancer immunotherapy: a patent review (2018-2019)

Published:2020-09-01 Issue:9 Volume:30 Page:677-694
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Geng Qiaohong¹,Rohondia Sagar O.²,Khan Harras J.²,Jiao Peifu¹,Dou Q. Ping²

Affiliation:

1. Department of Chemistry, Qilu Normal University, Jinan, China

2. Barbara Ann Karmanos Cancer Institute, and Departments of Oncology, Pharmacology and Pathology, School of Medicine, Wayne State University, Detroit, MI, USA

Funder

National Cancer Institute

National Institutes of Health

Province Higher Educational Science and Technology

Shandong Province Higher Educational Reformation Program

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2020.1801640

Reference127 articles.

1. The future of immune checkpoint therapy

2. The blockade of immune checkpoints in cancer immunotherapy

3. Advances in cancer immunotherapy 2019 – latest trends

4. Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential

5. Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-PD-L1-Based Bispecific Antibodies Targeting Co-Inhibitory and Co-Stimulatory Molecules for Cancer Immunotherapy;Molecules;2024-01-17

2. Synthesis and evaluation of indole-containing derivatives as C-linked PD-L1 inhibitors for cancer immunotherapy;Journal of Molecular Structure;2023-12

3. Synthesis and preliminary evaluation of aminophenol derivatives as molecular glues blocking PD-1/PD-L1 interaction;Journal of Molecular Structure;2023-10

4. Perioperative immunotherapy for esophageal squamous cell carcinoma: Now and future;World Journal of Gastroenterology;2023-09-14

5. Quantification of the growth suppression of HER2+ breast cancer colonies under the effect of trastuzumab and PD-1/PD-L1 inhibitor;Frontiers in Oncology;2022-12-21